France Osteoarthritis Therapeutics Market Size & Outlook
Related Markets
France osteoarthritis therapeutics market highlights
- The France osteoarthritis therapeutics market generated a revenue of USD 122.7 million in 2025 and is expected to reach USD 195.0 million by 2033.
- The France market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
- In terms of segment, viscosupplements was the largest revenue generating product in 2025.
- Adipose Tissue Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
Osteoarthritis therapeutics market data book summary
| Market revenue in 2025 | USD 122.7 million |
| Market revenue in 2033 | USD 195.0 million |
| Growth rate | 5.8% (CAGR from 2026 to 2033) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Adipose Tissue Therapy |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Platelet-Rich Plasma (PRP) Therapy, Autologous Chondrocyte Implantation (ACI), Including MACI, Adipose Tissue Therapy, BMAC (Bone Marrow Aspirate Concentrate) Therapy, Stem Cell (other), Bone Graft Substitutes, Viscosupplements, Other (Cartilage Resurfacing Products) |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A |
Other key industry trends
- In terms of revenue, France accounted for 2.2% of the global osteoarthritis therapeutics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany osteoarthritis therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 41.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Therapeutics Market Scope
Osteoarthritis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Bioventus Inc Class A | View profile | 995 | 4721 Emperor Boulevard, Suite 100, Durham, NC, United States, 27703 | https://www.bioventus.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
France osteoarthritis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 70.82% in 2025. Horizon Databook has segmented the France osteoarthritis therapeutics market based on platelet-rich plasma (prp) therapy, autologous chondrocyte implantation (aci), including maci, adipose tissue therapy, bmac (bone marrow aspirate concentrate) therapy, stem cell (other), bone graft substitutes, viscosupplements, other (cartilage resurfacing products) covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to France osteoarthritis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France osteoarthritis therapeutics market databook
-
Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France osteoarthritis therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into France osteoarthritis therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
France Viscosupplementation Agents - Osteoarthritis Therapeutics Market size, 2025 - 2033 (US$M)
France Osteoarthritis Therapeutics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
